Rhelion Life Sciences Corp. RHEL
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.72M | 6.49M | 7.21M | 7.70M | 8.56M |
| Total Receivables | 319.90K | 342.80K | 594.60K | 360.50K | 357.00K |
| Inventory | 268.60K | 606.20K | 688.10K | 736.40K | 744.80K |
| Prepaid Expenses | 157.60K | 127.30K | 289.60K | 305.80K | 317.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.34M | 1.36M | 1.64M | 1.62M | 1.65M |
| Total Current Assets | 7.81M | 8.92M | 10.42M | 10.72M | 11.63M |
|
|
|||||
| Total Current Assets | 7.81M | 8.92M | 10.42M | 10.72M | 11.63M |
| Net Property, Plant & Equipment | 1.27M | 1.09M | 2.36M | 2.45M | 2.56M |
| Long-term Investments | 4.69M | -- | -- | -- | -- |
| Goodwill | 4.69M | -- | -- | -- | -- |
| Total Other Intangibles | 323.90K | -- | -- | 4.20K | 10.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.39M | 10.44M | 13.27M | 13.65M | 14.77M |
|
|
|||||
| Total Accounts Payable | 1.03M | 452.70K | 653.40K | 597.60K | 645.00K |
| Total Accrued Expenses | 498.20K | 930.00K | 634.00K | 574.20K | 516.70K |
| Short-term Debt | 814.90K | 811.30K | 954.90K | 813.30K | 830.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 57.20K | 45.60K | 44.90K | 66.30K | 64.70K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 16.80K | 22.50K |
| Total Other Current Liabilities | -- | -- | -- | 16.80K | 22.50K |
| Total Current Liabilities | 2.40M | 2.24M | 2.29M | 2.07M | 2.08M |
|
|
|||||
| Total Current Liabilities | 2.40M | 2.24M | 2.29M | 2.07M | 2.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 814.90K | 811.30K | 954.90K | 813.30K | 830.60K |
| Capital Leases | 146.10K | 159.80K | 175.20K | 207.70K | 225.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 147.50K | -- | 151.10K | 169.30K | 196.60K |
| Total Liabilities | 2.69M | 2.40M | 2.61M | 2.45M | 2.50M |
|
|
|||||
| Common Stock & APIC | 40.51M | 35.20M | 35.98M | 35.10M | 35.81M |
| Retained Earnings | -35.33M | -34.60M | -33.31M | -31.78M | -31.62M |
| Treasury Stock & Other | 8.06M | 7.98M | 8.05M | 7.92M | 8.09M |
| Total Common Equity | 13.24M | 8.57M | 10.72M | 11.24M | 12.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.24M | 8.57M | 10.72M | 11.24M | 12.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -540.70K | -534.30K | -55.10K | -31.10K | -14.70K |
| Total Equity | 12.70M | 8.04M | 10.66M | 11.21M | 12.27M |
|
|
|||||